140 related articles for article (PubMed ID: 10521789)
21. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas.
Takenaga K; Nakanishi H; Wada K; Suzuki M; Matsuzaki O; Matsuura A; Endo H
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2309-16. PubMed ID: 9815629
[TBL] [Abstract][Full Text] [Related]
22. Loss of KAI1 expression in the progression of colorectal cancer.
Lombardi DP; Geradts J; Foley JF; Chiao C; Lamb PW; Barrett JC
Cancer Res; 1999 Nov; 59(22):5724-31. PubMed ID: 10582691
[TBL] [Abstract][Full Text] [Related]
23. Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis.
Tang R; Cheng AJ; Wang JY; Wang TC
Cancer Res; 1998 Sep; 58(18):4052-4. PubMed ID: 9751608
[TBL] [Abstract][Full Text] [Related]
24. A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer.
Brunton VG; Ozanne BW; Paraskeva C; Frame MC
Oncogene; 1997 Jan; 14(3):283-93. PubMed ID: 9018114
[TBL] [Abstract][Full Text] [Related]
25. Low colonic glutathione detoxification capacity in patients at risk for colon cancer.
Grubben MJ; van den Braak CC; Nagengast FM; Peters WH
Eur J Clin Invest; 2006 Mar; 36(3):188-92. PubMed ID: 16506964
[TBL] [Abstract][Full Text] [Related]
26. Expression and activity of mitogen activated protein kinases in human colorectal carcinoma.
Eggstein S; Franke M; Kutschka I; Manthey G; von Specht BU; Ruf G; Farthmann EH
Gut; 1999 Jun; 44(6):834-8. PubMed ID: 10323886
[TBL] [Abstract][Full Text] [Related]
27. Wnt signaling regulates expression of the receptor tyrosine kinase met in colorectal cancer.
Boon EM; van der Neut R; van de Wetering M; Clevers H; Pals ST
Cancer Res; 2002 Sep; 62(18):5126-8. PubMed ID: 12234972
[TBL] [Abstract][Full Text] [Related]
28. Protein tyrosine kinase in colorectal adenoma.
Hatada T; Sakanoue Y; Kusunoki M; Yanagi H; Yamamura T; Utsunomiya J
Acta Oncol; 1993; 32(1):23-8. PubMed ID: 8466759
[TBL] [Abstract][Full Text] [Related]
29. Change in telomerase activity during human colorectal carcinogenesis.
Yoshida R; Kiyozuka Y; Ichiyoshi H; Senzaki H; Takada H; Hioki K; Tsubura A
Anticancer Res; 1999; 19(3B):2167-72. PubMed ID: 10472326
[TBL] [Abstract][Full Text] [Related]
30. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
Alqurashi N; Gopalan V; Smith RA; Lam AK
Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
[TBL] [Abstract][Full Text] [Related]
31. Receptor tyrosine kinases expressed in metastatic colon cancer.
Craven RJ; Xu LH; Weiner TM; Fridell YW; Dent GA; Srivastava S; Varnum B; Liu ET; Cance WG
Int J Cancer; 1995 Mar; 60(6):791-7. PubMed ID: 7896447
[TBL] [Abstract][Full Text] [Related]
32. Protein kinase C tissue localization in human colonic tumors suggests a role for adenoma growth control.
Kahl-Rainer P; Sedivy R; Marian B
Gastroenterology; 1996 Jun; 110(6):1753-9. PubMed ID: 8964400
[TBL] [Abstract][Full Text] [Related]
33. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
34. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
[TBL] [Abstract][Full Text] [Related]
35. Estrogen Receptor β as a Prognostic Marker of Tumor Progression in Colorectal Cancer with Familial Adenomatous Polyposis and Sporadic Polyps.
Stevanato Filho PR; Aguiar Júnior S; Begnami MD; Ferreira FO; Nakagawa WT; Spencer RMSB; Bezerra TS; Boggiss PE; Lopes A
Pathol Oncol Res; 2018 Jul; 24(3):533-540. PubMed ID: 28681123
[TBL] [Abstract][Full Text] [Related]
36. Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells.
Lin Q; Lai R; Chirieac LR; Li C; Thomazy VA; Grammatikakis I; Rassidakis GZ; Zhang W; Fujio Y; Kunisada K; Hamilton SR; Amin HM
Am J Pathol; 2005 Oct; 167(4):969-80. PubMed ID: 16192633
[TBL] [Abstract][Full Text] [Related]
37. Site-specific differences in pp60c-src activity in human colorectal metastases.
Termuhlen PM; Curley SA; Talamonti MS; Saboorian MH; Gallick GE
J Surg Res; 1993 Apr; 54(4):293-8. PubMed ID: 7687314
[TBL] [Abstract][Full Text] [Related]
38. Expression of erythropoietin and its receptor increases in colonic neoplastic progression: the role of hypoxia in tumorigenesis.
Gombos Z; Danihel L; Repiska V; Acs G; Furth E
Indian J Pathol Microbiol; 2011; 54(2):273-8. PubMed ID: 21623073
[TBL] [Abstract][Full Text] [Related]
39. Coexpression of ephrin-Bs and their receptors in colon carcinoma.
Liu W; Ahmad SA; Jung YD; Reinmuth N; Fan F; Bucana CD; Ellis LM
Cancer; 2002 Feb; 94(4):934-9. PubMed ID: 11920461
[TBL] [Abstract][Full Text] [Related]
40. Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma.
Bergheim I; Bode C; Parlesak A
BMC Gastroenterol; 2005 Nov; 5():34. PubMed ID: 16281975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
